Marker Therapeutics Inc (MRKR)
4.29
-0.08
(-1.72%)
USD |
NASDAQ |
Apr 26, 16:00
4.29
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Cash from Operations (TTM): -16.44M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.44M |
| September 30, 2023 | -20.38M |
| June 30, 2023 | -26.90M |
| March 31, 2023 | -20.63M |
| December 31, 2022 | -26.97M |
| September 30, 2022 | -25.52M |
| June 30, 2022 | -25.41M |
| March 31, 2022 | -31.41M |
| December 31, 2021 | -27.28M |
| September 30, 2021 | -27.93M |
| June 30, 2021 | -26.52M |
| March 31, 2021 | -24.04M |
| December 31, 2020 | -20.03M |
| September 30, 2020 | -19.09M |
| June 30, 2020 | -18.63M |
| March 31, 2020 | -18.50M |
| December 31, 2019 | -18.28M |
| September 30, 2019 | -19.89M |
| June 30, 2019 | -17.79M |
| March 31, 2019 | -16.01M |
| December 31, 2018 | -14.48M |
| September 30, 2018 | -10.80M |
| June 30, 2018 | -9.249M |
| March 31, 2018 | -8.862M |
| December 31, 2017 | -8.439M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.715M |
| June 30, 2017 | -7.662M |
| March 31, 2017 | -7.604M |
| December 31, 2016 | -6.510M |
| September 30, 2016 | -5.607M |
| June 30, 2016 | -5.300M |
| March 31, 2016 | -4.159M |
| December 31, 2015 | -4.343M |
| September 30, 2015 | -4.162M |
| June 30, 2015 | -3.403M |
| March 31, 2015 | -2.829M |
| December 31, 2014 | -2.187M |
| September 30, 2014 | -1.458M |
| June 30, 2014 | -0.6864M |
| March 31, 2014 | -0.6131M |
| December 31, 2013 | -0.6946M |
| September 30, 2013 | -1.247M |
| June 30, 2013 | -1.384M |
| March 31, 2013 | -1.711M |
| December 31, 2012 | -1.589M |
| September 30, 2012 | -1.529M |
| June 30, 2012 | -1.398M |
| March 31, 2012 | -1.238M |
| December 31, 2011 | -1.310M |
| September 30, 2011 | -0.9101M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.41M
Minimum
Mar 2022
-16.44M
Maximum
Dec 2023
-22.72M
Average
-20.63M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Electromed Inc | 4.872M |
| Armata Pharmaceuticals Inc | -47.42M |